Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels
- PMID: 38401142
- DOI: 10.1111/apt.17881
Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels
Comment in
-
Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels-authors' reply.Aliment Pharmacol Ther. 2024 Mar;59(6):797-798. doi: 10.1111/apt.17907. Aliment Pharmacol Ther. 2024. PMID: 38401143 No abstract available.
Comment on
-
Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed nonalcoholic steatohepatitis.Aliment Pharmacol Ther. 2023 Nov;58(10):1005-1015. doi: 10.1111/apt.17709. Epub 2023 Sep 18. Aliment Pharmacol Ther. 2023. PMID: 37718721
References
REFERENCES
-
- Alkhouri N, Lazas D, Loomba R, Frias JP, Feng S, Tseng L, et al. Clinical trial: effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed nonalcoholic steatohepatitis. Aliment Pharmacol Ther. 2023;58:1005-1015.
-
- Newsome PN, Ambery P. Incretins (GLP-1 receptor agonists and dual/triple agonists) and the liver. J Hepatol. 2023;79:1557-1565.
-
- Flippo KH, Potthoff MJ. Metabolic messengers: FGF21. Nat Metab. 2021;3:309-317.
-
- Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Aging. 2019;48:16-31.
-
- Bishop CW, Bowen PE, Ritchey SJ. Norms for nutritional assessment of American adults by upper arm anthropometry. Am J Clin Nutr. 1981;34:2530-2539.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources